Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Mti-31 (LXI-15029) | 1567915-38-1 | 100.0% | 474.55 g/mol | C26H30N6O3 | 25MG
Supplier: Medchemexpress LLC HY12607725MG
MTI-31 (LXI-15029) is a potent, selective dual mTORC1/mTORC2 inhibitor used in preclinical cancer research. It exhibits high affinity for mTOR (reported Kd ≈ 0.20 nM; IC50 ≈ 39 nM) and has demonstrated inhibition of tumor growth, epithelial-mesenchymal transition, and metastasis in model systems. Supplied as a white-to-yellow solid for research use only.
- Potent dual mTORC1/mTORC2 inhibition with subnanomolar binding affinity.
- Demonstrated activity in preclinical tumor and metastasis models.
- High reported purity for analytical consistency.
- Stable solid form with recommended refrigerated storage conditions.
- Suitable for both in vitro and in vivo research applications.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?